文献速递糖尿病

1型糖尿病妊娠期传感器增强泵预测性低血糖暂停与低血糖暂停的酮血症风险:交叉RCT

Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT.
PubMed 文献 · Diabetologia · 2021-10-13

结果显示PLGS组胰岛素暂停时间更长(3.5 h vs 2.0 h,p=0.002),但酮血症>0.6 mmol/l频率与LGS组无差异(0.5% vs 0%,p=1.000),且PLGS组低血糖时间更少(4.2% vs 7.5%,p=0.014),TIR相似。

要点

  • PLGS模式不增加1型糖尿病孕妇酮血症风险。
  • PLGS模式低血糖时间更少,TIR与LGS相似。
  • PLGS模式胰岛素暂停时间更长但未导致酮血症增加。

核心结论

  • 使用传感器增强泵PLGS模式的1型糖尿病孕妇尽管胰岛素暂停时间更长,但酮血症风险不高于LGS模式。
  • PLGS模式TIR相似且低血糖时间更少。

研究设计与样本

  • 每日三次测量血清酮体,主要终点为血酮>0.6 mmol/l的频率。

主要发现

  • LGS vs PLGS:每日胰岛素暂停时间2.0 h(1.3-2.3)vs 3.5 h(3.3-5.0),p=0.002。
  • 酮血症>0.6 mmol/l频率:LGS 0% vs PLGS 0.5%,p=1.000;无参与者血酮>1 mmol/l。
  • TIR:LGS 64.7%(58.0-68.7)vs PLGS 61.1%(56.5-67.5),p=0.492。
  • 时间<3.5 mmol/l:LGS 7.5%(4.6-8.3)vs PLGS 4.2%(2.4-6.9),p=0.014。
  • 治疗满意度和低血糖恐惧在两种模式间相似。

临床怎么用

  • 1型糖尿病孕妇使用PLGS模式不增加酮血症风险,且低血糖时间更少,可考虑作为妊娠期血糖管理选项。

局限性

  • 开放标签设计,参与者和医疗提供者未设盲。
  • 研究期间无特定资助。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To determine the frequency of ketonaemia in pregnant women with type 1 diabetes treated with a sensor-augmented pump (SAP) in predictive low glucose suspend (PLGS) mode compared with low glucose suspend (LGS) mode. METHODS: An open-label crossover pilot RCT in ten women with type 1 diabetes treated with a 640 Medtronic insulin pump, with inclusion between 12-30 weeks of pregnancy. Participants were 1/1 randomly assigned (allocation by statistician using a permuted block size of 2) to either 2 weeks with an SAP in PLGS mode or 2 weeks in LGS mode. After the first 2 weeks, participants were switched to the other mode. Ketones in the participants' serum were measured three times daily (fasting, midday and evening) during the 4 weeks. The primary endpoint was the frequency of blood ketones > 0.6 mmol/l. Participants and healthcare providers were not blinded to group assignment for assessment of outcomes. RESULTS: The median gestational week at inclusion was 12.5 weeks (12.0-15.0), participants had a median age of 31.5 years (24.0-33.0), BMI of 26.6 kg/m2 (24.5-31.8), baseline HbA1c of 41 mmol/mol (40-43; 5.9% [5.8-6.1]) and baseline time in range (TIR, 3.5-7.8 mmol/l) of 64.6% (55.6-68.7). Comparing the LGS mode with the PLGS mode, insulin suspension time per day was 2.0 h (1.3-2.3) vs 3.5 h (3.3-5.0; p = 0.002), ketonaemia > 0.6 mmol/l was 0% vs 0.5% (p = 1.000) and no participants had ketonaemia > 1 mmol/l. TIR on LGS was 64.7% (58.0-68.7) vs 61.1% (56.5-67.5) on PLGS (p = 0.492), time < 3.5 mmol/l was higher on LGS at 7.5% (4.6-8.3) vs 4.2% (2.4-6.9) on PLGS (p = 0.014). Treatment satisfaction and fear for hypoglycaemia were similar whether using LGS or PLGS mode. CONCLUSIONS/INTERPRETATION: Despite longer time periods with suspended insulin delivery, pregnant women using an SAP in PLGS mode were not at higher risk of developing ketonaemia compared with those in LGS mode. Women with an SAP in PLGS mode had similar TIR with less time in hypoglycaemia. TRIAL REGISTRATION: Clinical Trials NCT04292509 FUNDING: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Benhalima K, van Nes F, Laenen A, et al. Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT. Diabetologia. 2021. PMID: 34647140. doi:10.1007/s00125-021-05589-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。